Novartis, Regenerex further immune tolerance R&D
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2013
Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a bi...Read more
Boehringer Ingelheim appoints board member
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jul, 2012
Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board...Read more
China develops revolutionary TCM migraine medication
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2012
Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...Read more
Novartis eye care firm gets EU nod for Jetrea
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 18 Mar, 2013
Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval ...Read more
QRxPharma to resubmit NDA to FDA for pain relieving drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Applicat...Read more
Gilead HIV/AIDS 'blood booster' gets EU nod
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 26 Sep, 2013
Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobi...Read more
Merck, AstraZeneca sign deal for cancer drug therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2013
Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 ki...Read more
Inversion of ibuprofen in body helps fight cancer: Study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2013
Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inf...Read more
Australia ideal for early-stage drug development
Drug Discovery | Opinion | By BioSpectrum Bureau | 2 Comment | 14 Jun, 2012
Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900...Read more
HUYA, Sanzao Park partner for drug development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partne...Read more
GSK's cancer drug gets EU marketing authorization
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 16 Aug, 2013
Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used ...Read more
Astellas completes patient recruitment in drug trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...Read more
Daiichi Sankyo expands drug discovery program
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013
Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...Read more
Boehringer terminates insulin deal with Lilly
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2013
Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to...Read more
Cellmid gets positive sign with Midkine antibody for kidney disease
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (...Read more
Takeda Gemini II trial shows positive results
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...Read more
IOF, Fonterra grants $43K to Indonesian for bone R&D
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...Read more
Vanda Pharma withdraws application for Fanaptum
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 15 Mar, 2013
Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketin...Read more